New drug aims to ease muscle weakness in myasthenia gravis
NCT ID NCT07596901
First seen May 20, 2026 · Last updated May 20, 2026
Summary
This study tests a new drug called aritinercept in people with generalized myasthenia gravis, a condition that causes muscle weakness. The drug works by blocking two proteins that may drive the disease. Researchers want to see if it is safe and can improve daily activities. About 81 adults aged 18 to 85 will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYASTHENIA GRAVIS, GENERALIZED are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Aurinia Investigational Site
RECRUITINGAltamonte Springs, Florida, 32714, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Aurinia Investigational Site
RECRUITINGBoca Raton, Florida, 33487, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Aurinia Investigational Site
RECRUITINGMiami, Florida, 33173, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.